CLDI logo

Calidi Biotherapeutics (CLDI) Cash From Operations

Annual CFO

-$26.98 M
-$13.77 M-104.20%

December 31, 2023


Summary


Performance

CLDI Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLDIcash flowmetrics:

Quarterly CFO

-$4.95 M
+$548.00 K+9.97%

September 30, 2024


Summary


Performance

CLDI Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLDIcash flowmetrics:

TTM CFO

-$19.46 M
+$8.57 M+30.58%

September 30, 2024


Summary


Performance

CLDI TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLDIcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CLDI Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-104.2%+63.4%+10.7%
3 y3 years-459.1%+63.4%+10.7%
5 y5 years-459.1%+63.4%+10.7%

CLDI Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-247.1%at low-59.2%+63.4%-108.4%+30.6%
5 y5-year-459.1%at low-59.2%+63.4%-108.4%+30.6%
alltimeall time-459.1%at low-59.2%+63.4%-108.4%+30.6%

Calidi Biotherapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.95 M(-10.0%)
-$19.46 M(-30.6%)
Jun 2024
-
-$5.49 M(+43.4%)
-$28.03 M(+1.2%)
Mar 2024
-
-$3.83 M(-26.1%)
-$27.71 M(+2.7%)
Dec 2023
-$26.98 M
-$5.19 M(-61.6%)
-$26.98 M(+23.8%)
Sep 2023
-
-$13.52 M(+161.3%)
-$21.80 M(+23.7%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$5.17 M(+66.5%)
-$17.62 M(+41.6%)
Mar 2023
-
-$3.11 M(-66.7%)
-$12.45 M(+33.3%)
Dec 2022
-$13.21 M(+70.0%)
-
-
Sep 2022
-
-$9.34 M
-$9.34 M
Dec 2021
-$7.77 M(+61.1%)
-
-
Dec 2020
-$4.83 M
-
-

FAQ

  • What is Calidi Biotherapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Calidi Biotherapeutics?
  • What is Calidi Biotherapeutics annual CFO year-on-year change?
  • What is Calidi Biotherapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Calidi Biotherapeutics?
  • What is Calidi Biotherapeutics quarterly CFO year-on-year change?
  • What is Calidi Biotherapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Calidi Biotherapeutics?
  • What is Calidi Biotherapeutics TTM CFO year-on-year change?

What is Calidi Biotherapeutics annual cash flow from operations?

The current annual CFO of CLDI is -$26.98 M

What is the all time high annual CFO for Calidi Biotherapeutics?

Calidi Biotherapeutics all-time high annual cash flow from operations is -$4.83 M

What is Calidi Biotherapeutics annual CFO year-on-year change?

Over the past year, CLDI annual cash flow from operations has changed by -$13.77 M (-104.20%)

What is Calidi Biotherapeutics quarterly cash flow from operations?

The current quarterly CFO of CLDI is -$4.95 M

What is the all time high quarterly CFO for Calidi Biotherapeutics?

Calidi Biotherapeutics all-time high quarterly cash flow from operations is -$3.11 M

What is Calidi Biotherapeutics quarterly CFO year-on-year change?

Over the past year, CLDI quarterly cash flow from operations has changed by +$8.57 M (+63.41%)

What is Calidi Biotherapeutics TTM cash flow from operations?

The current TTM CFO of CLDI is -$19.46 M

What is the all time high TTM CFO for Calidi Biotherapeutics?

Calidi Biotherapeutics all-time high TTM cash flow from operations is -$9.34 M

What is Calidi Biotherapeutics TTM CFO year-on-year change?

Over the past year, CLDI TTM cash flow from operations has changed by +$2.34 M (+10.74%)